HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: A collaborative transplant study report

Transplantation

Volumn 87, Issue 9, 2009, Pages 1367-1371

  Süsal, Caner ^a   Döhler, Bernd ^a   Sadeghi, Mahmoud ^a   Ovens, Jörg ^a   Opelz, Gerhard ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acute rejection; Early adverse events; HLA antibodies; Immediate function; Renal transplantation

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA CLASS 1 ANTIBODY; HLA CLASS 2 ANTIBODY; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CREATININE CLEARANCE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL TIME;

ADULT; AGED; AUTOANTIBODIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL ANALYSIS; TRANSPLANTATION IMMUNOLOGY; TREATMENT FAILURE;

EID: 67649604481     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a24073     Document Type: Article

References (16)

1. Opelz G, Döhler B. Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation 2008; 85: 661.
2. Humar A, Ramcharan T, Kandaswamy R, et al. Risk factors for slow graft function after kidney transplants: A multivariate analysis. Clin Transplant 2002; 16: 425.
3. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
4. Halloran PF, Hunsicker LG. Delayed graft function: State of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001; 1: 115.
5. McLaren AJ, Jassem W, Gray DW, et al. Delayed graft function: Risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant1999; 13: 266.
6. Arias M. Impact of the delayed graft function in hypersensitized kidney transplant patients. Transplant Proc 2003; 35: 1655.
7. Quiroga I, McShane P, Koo DD, et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689.
8. Gibney EM, Cagle LR, Freed B, et al. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006; 21: 2625.
9. Süsal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002; 73: 1269.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
11. Browne BJ, Holt CO, Emovon OE. Delayed graft function may not adversely affect short-term renal allograft outcome. Clin Transplant2003; 17(suppl 9): 35.
12. Süsal C, Opelz G. Good kidney transplant outcome in recipients with presensitization against HLA class II but not HLA class I. Hum Immunol2004; 65: 810.
13. Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008; 8: 2335.
14. Furness PN, Taub N. International variation in the interpretation of renal transplant biopsies: Report of the CERTPAP project. Kidney Int2001; 60: 1998.
15. Furness PN, Taub N, Assmann KJ, et al. International variation in histologic grading is large, and persistent feedback does not improve reproducibility. Am J Surg Pathol 2003; 27: 805.
16. Quiroga I, Salio M, Koo DD, et al. Expression of MHC class I-related Chain B (MICB) molecules on renal transplant biopsies. Transplantation2006; 81: 1196.